Trimetazidine HCl Pellets
Rraynex supplies Trimetazidine HCl Pellets as pellets in the Anti-Anginal (Fatty Acid Oxidation Inhibitor) category.
Product overview
Trimetazidine is an anti-anginal metabolic agent that shifts heart-muscle energy use away from fatty acid oxidation.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Pharmaceutical applications
- Capsule filling of trimetazidine hcl pellets for anti-anginal products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Trimetazidine HCl Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Anginal (Fatty Acid Oxidation Inhibitor)
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Trimetazidine HCl Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities